Nov 24, 2020, 01:00 AM by User Not Found

Bio-IT World | What started as a collaboration to study non-alcoholic fatty liver disease is shifting gears to tackle COVID-19. BERG and AdventHealth are partnering to apply AI to enhance COVID-19 patient care by rapidly identifying the right path to improve patient outcomes.

Nov 23, 2020, 01:00 AM by User Not Found

Bio-IT World | IBM CEO Arvind Krishna sees AI, hybrid cloud computing, and quantum computing as setting the future of the IT industry.

Nov 20, 2020, 10:29 AM by User Not Found

Bio-IT World I St. Jude discovers hyperinflammatory pathway, hepatitis C drugs are potential treatment, non-human primate model identifies features of virus, IL-10 production is a marker for severity, recommendations on re-use of data, molecular structure of key E-protein, and early antibody evolution predicts outcomes. Plus: Disrupting SKI complex prevents viral replication, why COVID-19 spares children, and how smoking causes more severe infection.

Nov 19, 2020, 15:06 PM by

InSysBio presents public version of CYTOCON DB entitled “CYTOCON DB Open”. Actually, CYTOCON DB Open has the same functionality as the initial version. However, CYTOCON DB Open is reduced and will be updated once per year. It concerns both content and functionality.

Nov 19, 2020, 15:06 PM by

Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round which will enable it to complete development of the design, electronics and software for submission to the regulatory authorities in both Europe and the US and continue through to commercial launch.

Nov 19, 2020, 15:06 PM by

The Platform Allows Pharmaceutical and Biopharmaceutical Companies as well as Clinics and Hospitals to Dramatically Accelerate Precise Cancer Diagnosis for Expediting Clinical Trials and Personalized Therapy

Nov 19, 2020, 15:02 PM by

Watson-Marlow Limited Ireland, award winning, global leader in fluid management technology, will open a state-of-the-art facility in Cork, Ireland. The new ISO 14644-1 Class 7 cleanroom will be added to the company’s existing Cork site and will be certified to meet the demands of the highly regulated pharmaceutical and biopharmaceutical manufacturing sector in Ireland.

Nov 19, 2020, 15:02 PM by

Nov 19, 2020, 14:59 PM by

The Verisense platform provides complete, high quality, reproducible clinical trial data, while placing minimum burden on sponsors, CROs, site staff and participants.

Nov 19, 2020, 14:59 PM by

Scilligence informatics platform users now have the ability to access CAS’s high-quality scientific content directly in our web-based informatics solutions, including Scilligence Inventory and Scilligence ELN.

Nov 19, 2020, 14:59 PM by

CMO growth hampered by innovator approvals from mega cap pharma, yet contract clinical and recombinant vector manufacturing growing in demand

Nov 19, 2020, 14:59 PM by

Ardigen and The BioCollective today announced a research collaboration aimed at the development of the world’s first microbiome-based biomarker candidates for Parkinson’s Disease.

Nov 19, 2020, 14:59 PM by

Nov 19, 2020, 14:57 PM by

A pilot trial at The Medication Adherence Expertise Center of the University Medical Center Groningen in the Netherlands is determining whether Pill Connect’s smart bottle system can support patients with tuberculosis (TB) with their medication adherence.

Nov 19, 2020, 14:56 PM by

Page & Page and Partners, the global creative communications agency specialising in health, wellness and lifestyle, is today announcing the appointment of three new staff members joining the team on a full time basis. The new joiners are: • Asma Shirazi - Account Director • Emily Sidlow - Senior Account Manager • Isabelle Nicholson-Rose - Account Executive They will all be joining the Client Services team, headed by Rachel Harris and will be working on clients including Novartis, Abbott Diagnostics, Fresenius Kabi, L&R, Align Technology and IQVIA.

Nov 19, 2020, 14:53 PM by

Potential for a New Standard of Care to Improve Diagnostic Accuracy for Breast Cancer Exclusively from H&E Biopsy/Resection Images

Nov 19, 2020, 14:52 PM by

Nov 19, 2020, 14:51 PM by

Nov 19, 2020, 01:00 AM by User Not Found

Bio-IT World | COVID-19 is switching the risk paradigm for biotech and pharma. It’s too risky, now, not to do something digital. It’s driving changes in investing as well. A recent panel discussion explored how venture capital and new tech companies evaluate technology, invest cash, and plan to move forward.

Nov 17, 2020, 01:00 AM by User Not Found

Bio-IT World | A decades-old technology initially used to hide secret messages in dots of DNA—along with Oxford Nanopore sequencing—could get a reboot as a tracking system for commodities that might be too small or numerous for tagging with QR codes or radio-frequency identification, such as experimental drugs and controlled substances.